Skip to main content
2022 PDTC Cover Image
Working with Us

2023 PD Therapeutics Conference

  • Register
About the Conference
2022 PDTC Panel Discussion

*At this time, there are no current CDC guideline or local rules and regulations in place for COVID-19. As such, this meeting will not require proof of vaccination or testing, and while masking is encouraged, it will be optional. As the course of the pandemic shifts or local, state or federal regulations change, we will follow science and update all attendees. For international attendees, please make sure to check the rules on arrival and departure with your country and the United States. The Parkinson's Disease Therapeutics Conference is The Michael J. Fox Foundation's annual scientific conference and the only one in the world focused exclusively on Parkinson's disease drug development. The 15th Annual PD Therapeutics Conference is scheduled to be held on October 19, 2023, in New York.

Each year, the PD Therapeutics Conference brings together 300 research and business development professionals from both academia and industry and showcases the most exciting and innovative research from MJFF's research portfolio. Novel advances in basic and translational research from both academic and industry labs are highlighted through speaker presentations and a poster session. The event is a platform for field leaders to share new and unpublished results and for fostering new relationships and collaborations.

REGISTER HERE > 

For Questions or Updates,

Please contact researchmeetings@michaeljfox.org.

Conference Schedule (subject to change)
7:45
ARRIVALS & BREAKFAST
8:30-8:45
WELCOME REMARKS
Sohini Chowdhury | The Michael J. Fox Foundation
8:45-11:10
Session 1: Advances in Emerging Targets and Therapeutic Development
SESSION INTRODUCTION by Session Chair
Session Chair: Karoly Nikolich, PhD | Alkahest Inc.
GP2 Presentation
Speaker: Andrew Singleton, PhD | National Institutes of Health
TMEM175 Activators Presentation
Speaker: David Stone, PhD | Cerevel Therapeutics
USP30 Presentation
Speaker: Paul Thompson, PhD | Mission Therapeutics
Kv1.3 Presentation
Speaker: Niels Plath, PhD | Muna Therapeutics
CLOSING REMARKS from Session Chair
Karoly Nikolich, PhD | Alkahest Inc.
10:40 - 11:10
Networking Break / Poster Viewing
11:10 - 12:20
Session 2: Advances in the Classification and Measurement of Parkinson's
SESSION INTRODUCTION by Session Chair
Kathleen Poston, MD, MS | Stanford University
Neuropathology to Biological PD
Speaker: Tom Montine, MD, PhD | Stanford University
The PD Integrated Staging System
Speaker: Ken Marek, MD | Institute of Neurodegenerative Disorders
Where We Are with SAA
Speaker: Kalpana Merchant, PhD | TransThera Consulting
12:20 - 1:25
Networking Break / Poster Viewing / Lunch
Overview of MJFF Molecular Imaging Consortium
Speaker: Jamie Eberling, PhD | The Michael J. Fox Foundation
Patient Meaningfulness of Digital Health Technologies
Speaker: Jamie Adams, MD | University of Rochester
Mitochondrial Biomarkers Presentation
Speaker: Bill Shrader, PhD | AcureX
CLOSING REMARKS from Session Chair
Kathleen Poston, MD, MS | Stanford University
2:40 - 3:10
Networking Break / Poster Viewing
3:10 - 4:40
Session 3: Panel Discussions
Applying the PD-Integrated Staging System to Clinical Trials
Moderator: Karl Kieburtz, MD, MPH | University of Rochester; Panelists: Gennaro Pagano, MD, PhD | Roche; Tien Dam, MD | Biogen; Tanya Fischer, MD, PhD | Biohaven
Panel on Patient Preferences
Moderator: Katie Kopil, PhD | The Michael J. Fox Foundation; Panelists: Vicky DiBiaso, PhD | Sanofi; Gary Rafaloff | MJFF Patient Council; Soania Mathur, MD | MJFF Patient Council
CLOSING REMARKS
Speaker: Sohini Chowdhury | The Michael J. Fox Foundation
4:40 - 6:00
Cocktail Reception / Poster Viewing
Speakers

Jamie Adams, MD | University of Rochester 

Tien Dam, MD | Biogen

Vicky DiBiaso, PhD | Sanofi 

Jamie Eberling, PhD | The Michael J. Fox Foundation 

Tanya Fischer, MD, PhD | Biohaven

Karl Kieburtz, MD, MPH | University of Rochester 

Catherine Kopil, PhD | The Michael J. Fox Foundation 

Ken Marek, MD | Institute for Neurodegenerative Disorders 

Soania Mathur, MD | MJFF Patient Council Member 

Kalpana Merchant, PhD | TransThera Consulting 

Tom Montine, MD, PhD | Stanford University 

Karoly Nikolich, PhD | Alkahest Inc.

Gennaro Pagano, MD, PhD | Roche 

Niels Plath, PhD | Muna Therapeutics 

Kathleen Poston, MD, MS | Stanford University 

Gary Rafaloff | MJFF Patient Council Member 

Andrew Singleton, PhD | National Institutes of Health

David Stone, PhD | Cerevel Therapeutics

Bill Shrader, PhD | AcureX 

Paul Thompson, PhD | Mission Therapeutics 

Posters
  • Posters

    Coming soon!

Conference Sponsors

The 15th annual Parkinson's Disease Therapeutics Conference is made possible by the support of our generous sponsors: 

 

BioLegend

Interested in Sponsorship Opportunities?

View our sponsorship opportunities menu to support this year's conference.

Contact our Research Alliances team at researchpartnerships@michaeljfox.org with questions. 

About the Venue

Address

Quorum by Convene 
1221 Avenue of Americas
New York, NY 10020

Convene

 

We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.